Every other Monday, ACCC highlights the latest news, announcements, resources, and innovations from our member cancer programs. To submit your program, visit the Member News Submission Portal and complete a brief form.
Congratulations to Indiana University Melvin and Bren Simon Cancer Center on becoming designated a Comprehensive Cancer Center by the National Cancer Institute (NCI)! The cancer center received an "Outstanding" rating from NCI reviewers and has been awarded a five-year, $13.8 million grant to support the center's research programs and shared facilities.
In more NCI-related news, Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine was recently awarded a six-year, $7.8 million grant through NCI's National Clinical Trials Network to continue its role as a Lead Academic Participating Site. The designation recognizes the center's ability to enroll large numbers of patients and its leadership in clinical trial implementation.
Researchers from the Abramson Cancer Center at the University of Pennsylvania have discovered that a crucial signaling pathway that can tell immune systems to fight cancer can be overwritten by cancer cells. This understanding can improve both identification through biomarkers and immunotherapy implementation.
The Charles A. and Betty Bott Cancer Center at Holy Redeemer Hospital and Medical Center recently received three-year accreditation from the American College of Surgeons' Commission on Cancer! The cancer center received Silver-Level Commendation for its demonstrated excellence in comprehensive, patient-centered cancer care delivery.
At the 2026 ASCO Annual Meeting, the Louisiana Oncology Society received the ASCO Jeffrey C Ward Affiliate Advocacy Award for advancing critical advocacy priorities that have translated into meaningful legislative victories. The Iowa Oncology Society and Washington State Medical Oncology Society were also recognized for their advocacy efforts in 2025 at the meeting, receiving second place awards.
